BioNTech launches containerised vaccine manufacturing facility


German company Biopharmaceutical New Technologies (BioNTech) has announced a containerised, turnkey and scalable production plant for mRNA-based vaccine production.

Do you want to read the full article?

Register to continue reading

By registering you will have:

  • Access to all Premium content
  • Discount on selected events
  • Full access to the entire digital archive
  • 10x per year Digital Magazine

SUBSCRIBE or, if you are already a member Log In


Having problems logging in? Call +31(0)10 280 1000 or send an email to